Direct line: 1300 987 995
Feb 17 (Reuters) - Prana Biotechnology Ltd
* Trading halt
* Seeks trading halt pending announcement for market in relation to results of its reach2hd phase 2 huntington's disease trial
* Source text for Eikon
* ((For more news, please click here
((Bangalore Newsroom; +91 80 6749 1130))